X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

GILD

Closed

Gilead Sciences Inc

111.73
+0.86 (+0.78%)
Last Update: 01 Jul 2025 23:26:00
Yesterday: 110.87
Day's Range: 110.8 - 112.565
Send
When Written:
 
83.6799
Gilead Sciences Inc. is a biopharmaceutical company that develops and commercializes therapies for life-threatening diseases. The company was founded in 1987 and is headquartered in Foster City, California. Gilead Sciences is known for developing antiviral drugs for the treatment of HIV/AIDS, hepatitis B, and hepatitis C. The company's most successful drug is Sovaldi, which was approved by the FDA in 2013 for the treatment of hepatitis C. Gilead Sciences has also developed drugs for the treatment of cancer, respiratory diseases, and cardiovascular diseases. The company has operations in North America, Europe, and Asia, and has a workforce of over 12,000 employees worldwide.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X